201 related articles for article (PubMed ID: 15486990)
1. Regional cerebral blood flow in children with attention deficit hyperactivity disorder: comparison before and after methylphenidate treatment.
Lee JS; Kim BN; Kang E; Lee DS; Kim YK; Chung JK; Lee MC; Cho SC
Hum Brain Mapp; 2005 Mar; 24(3):157-64. PubMed ID: 15486990
[TBL] [Abstract][Full Text] [Related]
2. The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders.
Cho SC; Hwang JW; Kim BN; Lee HY; Kim HW; Lee JS; Shin MS; Lee DS
J Psychiatr Res; 2007 Sep; 41(6):459-65. PubMed ID: 16839567
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder.
Kim BN; Lee JS; Cho SC; Lee DS
Yonsei Med J; 2001 Feb; 42(1):19-29. PubMed ID: 11293498
[TBL] [Abstract][Full Text] [Related]
4. A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response.
Schweitzer JB; Lee DO; Hanford RB; Tagamets MA; Hoffman JM; Grafton ST; Kilts CD
Neuropsychopharmacology; 2003 May; 28(5):967-73. PubMed ID: 12700698
[TBL] [Abstract][Full Text] [Related]
5. Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity.
Schweitzer JB; Lee DO; Hanford RB; Zink CF; Ely TD; Tagamets MA; Hoffman JM; Grafton ST; Kilts CD
Biol Psychiatry; 2004 Oct; 56(8):597-606. PubMed ID: 15476690
[TBL] [Abstract][Full Text] [Related]
6. The rCBF brain mapping in adolescent ADHD comorbid developmental coordination disorder and its changes after MPH challenging.
Yeh CB; Huang WS; Lo MC; Chang CJ; Ma KH; Shyu JF
Eur J Paediatr Neurol; 2012 Nov; 16(6):613-8. PubMed ID: 22417719
[TBL] [Abstract][Full Text] [Related]
7. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
[TBL] [Abstract][Full Text] [Related]
8. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder.
Schrantee A; Bouziane C; Bron EE; Klein S; Bottelier MA; Kooij JJS; Rombouts SARB; Reneman L
Brain Imaging Behav; 2018 Apr; 12(2):402-410. PubMed ID: 28321605
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder.
Langleben DD; Acton PD; Austin G; Elman I; Krikorian G; Monterosso JR; Portnoy O; Ridlehuber HW; Strauss HW
J Nucl Med; 2002 Dec; 43(12):1624-9. PubMed ID: 12468511
[TBL] [Abstract][Full Text] [Related]
11. Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study.
Chou TL; Chia S; Shang CY; Gau SS
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2300-10. PubMed ID: 26409297
[TBL] [Abstract][Full Text] [Related]
12. Treatment effect of methylphenidate on intrinsic functional brain network in medication-naïve ADHD children: A multivariate analysis.
Yoo JH; Kim D; Choi J; Jeong B
Brain Imaging Behav; 2018 Apr; 12(2):518-531. PubMed ID: 28417219
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term methylphenidate treatment: a pilot follow-up clinical and SPECT study.
Akay AP; Kaya GC; Emiroğlu NI; Aydin A; Monkul ES; Taşçi C; Miral S; Durak H
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1219-24. PubMed ID: 16616981
[TBL] [Abstract][Full Text] [Related]
14. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.
Shafritz KM; Marchione KE; Gore JC; Shaywitz SE; Shaywitz BA
Am J Psychiatry; 2004 Nov; 161(11):1990-7. PubMed ID: 15514398
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
[TBL] [Abstract][Full Text] [Related]
16. A Counting Stroop Functional Magnetic Resonance Imaging Study on the Effects of ORADUR-Methylphenidate in Drug-Naive Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Chou TL; Hsieh CY; Gau SS
J Child Adolesc Psychopharmacol; 2022 Nov; 32(9):467-475. PubMed ID: 36251766
[No Abstract] [Full Text] [Related]
17. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
Volkow ND; Wang GJ; Tomasi D; Kollins SH; Wigal TL; Newcorn JH; Telang FW; Fowler JS; Logan J; Wong CT; Swanson JM
J Neurosci; 2012 Jan; 32(3):841-9. PubMed ID: 22262882
[TBL] [Abstract][Full Text] [Related]
18. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
19. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
[TBL] [Abstract][Full Text] [Related]
20. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
Husarova V; Bittsansky M; Ondrejka I; Dobrota D
Psychiatry Res; 2014 Apr; 222(1-2):75-83. PubMed ID: 24679996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
